✦ LIBER ✦

Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens

✍ Scribed by Aman U. Buzdar; Sewa S. Legha; Gabriel N. Hortobagyi; Hwee-Yong Yap; Charles L. Wiseman; Alfred Distefano; Frank C. Schell; Brian C. Barnes; Luis T. Campos; George R. Blumenschein

Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 419 KB
Volume: 47
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19810615)47:12<2798::aid-cncr2820471207>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Status of adjuvant chemotherapy in patie

Status of adjuvant chemotherapy in patients with breast cancer

✍ David L. Ahmann 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Low tissue enzyme activity seen in breas

Low tissue enzyme activity seen in breast cancers of patients who fail adjuvant chemotherapy

✍ Edwin D. Savlov; Russell Hilf; Scott L. Gibson; Michael Feldstein 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 324 KB 👁 1 views

Efficacy of bone and liver scanning in b

Efficacy of bone and liver scanning in breast cancer patients treated with adjuvant chemotherapy

✍ Nelson B. Arnstein; John C. Harbert; Patrick J. Byrne 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 2 views

Effect of adjuvant chemotherapy on outco

Effect of adjuvant chemotherapy on outcome in patients with metastatic breast carcinoma treated with first-line doxorubicin-containing chemotherapy

✍ Jean-Yves Pierga; Bernard Asselain; Michel Jouve; Véronique Diéras; Mathieu Cart 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

## BACKGROUND. The objective of the current study was to analyze the impact of adjuvant chemotherapy in comparison with other prognostic parameters on the outcome of a series of patients with breast carcinoma at time of metastatic recurrence. ## METHODS. Data from 1430 patients accrued in 8 pro

Clinical course of patients with breast

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy

✍ Aman U. Buzdar; Shu-Wan Kau; Gabriel N. Hortobagyi; Frederick C. Ames; Frankie A 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 1 views

Responses to chemotherapy or chemohormon

Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy: A subset analysis of CALGB study 8081

✍ Carl G. Kardinal; Michael C. Perry; Ann H. Korzun; Mary Alice Rice; Sandra Ginsb 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 2 views

The Cancer and Leukemia Group B (CALGB) evaluated the response to subsequent chemotherapy or chemohormonal therapy in 46 patients with advanced breast cancer treated previously with adjuvant chemotherapy that had been completed 6 months or more before protocol entry. The results were compared with 3